Form D — Aspicio Therapeutics, Inc.
0002025735-26-000001 · filed Jul 17, 2026
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $200,000
- Total sold
- $200,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aspicio Therapeutics, Inc.
- CIK
- 2025735
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 250 TRUMAN WAY
DOWNINGTOWN, PA 19335 - Phone
- 484.885.4744
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Keane · Executive OfficerDowningtown, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗